XBI (SDPR S&P Biotech ETF) Posied for Upside Continuation?

XBI (SDPR S&P Biotech ETF) continues to carve out a high level bullish digestion pattern that when complete, should resolve itself in an upside continuation thrust that propels XBI to a next target zone of 85.80-86.20. Only a decline that prints 82.60 will invalidate the current, promising near term set up.